Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer
Clinical trial NCT00638391 · COMPLETED
Trial details
- NCT number
- NCT00638391
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-05-01
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.